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Summary
Objective: Although there have been several reports on the use of extracorporeal shock wave therapy (ESWT), the efﬁcacy of ESWT for knee
osteoarthritis (OA) has not been clariﬁed. The aim of this study is to investigate the effect of ESWT on OA in a rat knee model.
Methods: The ratsweredivided into threegroups: (1) control, (2)OA,and (3)ESWT(kneeOAþ shockwave therapy).Behavioralanalysisconsisted
ofmeasuring the duration ofwalking ona treadmill. Theexpression of calcitoningene-relatedpeptide (CGRP) indorsal root ganglion (DRG) neurons
innervating the knee using immunohistochemistry was examined in the three groups at their peak time point on the treadmill.
Results: Walking duration was signiﬁcantly extended 4, 7 and 14 days after ESWT in rats with knee OA (peak time point: 4 days), again de-
creasing by days 21 and 28. Immunohistochemical studies revealed that the OA group had signiﬁcantly higher percentages of CGRP positive
neurons in the DRG than were found in the control group. In addition, ESWT reduced the ratio of CGRP positive DRG neurons in the OA model.
Conclusion: The improvement in walking ability and the reduction of CGRP positive neurons in DRG indicates that ESWT is a useful treatment
for knee OA.
ª 2007 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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Chronic pain while walking and functional limitation are
some of the clinical manifestations of the osteoarthritis
(OA) knee in many of the elderly. The goal of management
of the patient with OA is control of pain and improvement in
function and quality of life.
The neuropeptide calcitonin gene-related peptide
(CGRP) is expressed by nociceptors and is thought to
play a role in the sensation of joint pain1. CGRP has been
shown by immunohistochemistry to be expressed in nerve
ﬁbers supplying the rat knee at both the level of the dorsal
root ganglion (DRG)2 and locally in the knee3. Increased
synthesis of CGRP peptides in DRG may play a role in
the pathogenesis of chronic arthritis4. A signiﬁcant de-
crease in the number of CGRP-immunoreactive (ir) DRG
neurons was found after rofecoxib treatment that was also
correlated with behavioral improvement4.
Recently, extracorporeal shock wave therapy (ESWT) has
been proven effective for pain relief and for stimulating heal-
ing of chronic tendinoses5. Although it has been reported that
ESWT is effective therapy for patients suffering from several
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Received 23 August 2006; revision accepted 12 March 2007.10kinds of orthopedic disorders5,6, there have been no studies
to reveal its effectiveness for the treatment of knee OA. The
aim of this study is to identify the effectiveness of ESWT for
an animal model of knee OA. Walking duration on a treadmill
was analyzed before and after treatment. In addition, immu-
nohistochemistry was used to observe changes in CGRP ex-
pression in theDRGneurons innervating the knee joints in rat
OA model.
Methods
ANIMALS
The experimental protocol was conducted in accordance
with the guidelines of the Ethics Review Committee of
Chiba University for Animal Experimentation. Thirty-three
male Sprague Dawley rats (Japan SLC, Japan) weighing
approximately 250 g were used for these studies. Surgery,
application of ESWT, and control study were carried out un-
der general anesthesia with 40 mg/kg sodium pentobarbital.
Fifteen rats were used for behavioral studies and 18 were
used for immunohistochemistry studies.
The OA model was induced by transection of both the
anterior cruciate ligament and medial collateral ligament
with microscissors and resection of the medial meniscus
as previously described7. In control-operated animals,
wounds were closed after subluxation of the patella. All
the rats were allowed to move freely in plastic cages until
10 weeks post-surgery.93
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Three control rats and 12 knee OA rats that were divided
into two groups were used for behavioral analysis: (1) con-
trol (three rats); (2) OA (six rats); and (3) ESWT (knee OA
and ESWT) (six rats) groups. An accelerating Rota-Rod
Treadmill (Ugo Basile, Italy) was used for behavioral tests
as previously described8. Walking duration was measured
before treatment and 4, 7, 14, 21, and 28 days after treat-
ment in the ESWT group. One thousand shock wave im-
pulses with an energy ﬂux density of 0.08 mJ/mm2 were
applied at a frequency of 4 Hz (Dornir MedTech.; Epos,
Germany) to the left medial side of the knees of six OA
model rats in the ESWT group. Only control and OA groups
were anesthetized without application of shock waves.
Walking time duration measurements were taken three
times at 5-min intervals each day. The average was calcu-
lated and used as the duration time. These times were
analyzed with a two-way analysis of variance (ANOVA) fol-
lowed by a Bonferroni post hoc test. A P value less than
0.05 was considered statistically signiﬁcant.
IMMUNOHISTOCHEMISTRY FOR CGRP IN DRG NEURONS
Eighteen animals were divided into three groups: (1) con-
trol (six knees); (2) OA (six knees); and (3) ESWT (six
knees). A medial para-patellar incision (approximately
5 mm) was made with the leg held in an extended position.
A perforation of approximately 0.5 mm in depth was made
on the medial side of the knee using a 27-gauge needle
and 50 ml of 10% w/v Fluoro-Gold crystals (FG; Fluoro-
chrome, Denver, CO) were inserted. Ten days after the
application of FG, ESWT was applied to six OA rats
(ESWT group) in the same manner as described above.
Only the control and OA groups were anesthetized without
application of shock waves. All rats were perfused 14 days
after application of FG as previously described9. The left
DRGs from L2 to L6 were harvested. The DRGs were im-
mersed in ﬁxative overnight at 4C, after which they were
transferred to 20% sucrose overnight9. Serial sections
(40 mm thick) were prepared from the DRGs using a cryostat
and mounted on poly-L-lysine-coated slides.
The sections were treated for 90 min at room temperature
in blocking solution (0.01 M phosphate buffered saline
(PBS) containing 0.3% Triton X-100 and 1% normal goat
serum). The DRGs were then incubated overnight at room
temperature with rabbit anti-CGRP (1:800; ImmunoStar,
Hudson, WI) diluted with blocking solution for 20 h at 4C.
After washing three times with PBS, sections were incu-
bated for 2 h in an Alexa Fluoro 488 with conjugated anti-
rabbit IgG (1:250; Molecular Probes, Eugene, OR). The
number of FG-labeled, and FG-labeled CGRP-ir DRG neu-
rons were counted using a ﬂuorescence microscope.
The major categories subjected to analysis were: (1) the
average number of FG-labeled neurons; and (2) the percent-
age of FG-labeled neurons that expressed CGRP (CGRP-ir
neurons), at three random sections for each harvested DRG.
Statistical analyses of these values were carried out using
a ManneWhitney Rank sum test. A P value less than 0.05
was considered statistically signiﬁcant.
Results
BEHAVIORAL TEST
The average walking duration times for control, ESWT
and OA groups are shown in Fig. 1. Walking duration timeof the ESWT and OA groups at time 0 was signiﬁcantly
shorter compared to the control group (P< 0.05). Walking
duration was signiﬁcantly increased by 4, 7, and 14 days
after ESWT (P< 0.05). However, there was no signiﬁcant
difference on the twenty-ﬁrst and twenty-eighth days com-
pared to the duration of walking before ESWT. Furthermore,
walking duration of the ESWT group was signiﬁcantly ex-
tended 4, 7, and 14 days after ESWT (P< 0.05) compared
to the OA group at each time point. However, there was no
signiﬁcant difference on the twenty-ﬁrst and twenty-eighth
days. Therefore, ESWT was effective for 14 days post-
treatment. Fig. 1 shows that peak walking duration time
was 4 days post-treatment. Therefore DRGs were harvested
on 4 days after ESWT for immunohistochemistry.
IMMUNOHISTOCHEMISTRY FOR CGRP
FG was retrogradely transported to the DRG neurons in-
nervating the knee joint [Fig. 2(A, C, E)]. The FG-labeled neu-
rons were distributed in the L2eL6 DRGs in all three groups.
There was no signiﬁcant difference in the average numbers
of FG-labeled neurons among the three groups (P> 0.05).
The average numbers of FG-labeled neurons were shown
(control group 8.2 3.8; OA group 8.2 3.7; ESWT group
9.8 4.7). Of the FG-labeled neurons innervating the
knee joints, the ratios of CGRP-ir neurons in control
(44.9 17.6%) and ESWT groups (43.8 12.7%) were sig-
niﬁcantly less than the ratio in the OA group (65.7 16.3%)
(P< 0.0001) [Fig. 2(B, D, F)]. ESWT reduced this ratio in
those neurons in the DRGs of the OA model. The numbers
and ratio for each group are shown as average SD.
Discussion
This study showed depression of CGRP in the DRG
neurons after the treatment by ESWT. The abundance of
CGRP-ir free nerve endings in the synovium corresponds
to the location of pain in knee OA10. Increasing the CGRP
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Fig. 1. Average walking duration on treadmill. The increase in walk-
ing duration was statistically signiﬁcant on days 4, 7, and 14 after
the application of shock waves. But there was no signiﬁcant differ-
ence on day 21 or day 28. Asterisks indicate statistical signiﬁcance
(*P< 0.05) compared to before ESWT and to the knee OA group.
Each point represents the mean value SD for the control, knee
OA, and ESWT groups.
1095Osteoarthritis and Cartilage Vol. 15, No. 9Fig. 2. Fluorescence photomicrographs of DRG neurons. Fluorescence photomicrographs showing DRG neurons labeled following FG appli-
cation to the knee (A, C, E). B, D and F show CGRP-ir DRG neurons. A and B are from the same section of L4 DRG in the control group, C and
D are from the same section of L4 DRG in the OA group, and E and F are from the same section of L4 DRG in the ESWT group. Arrowheads
indicate FG-labeled neurons that are CGRP-ir and asterisks indicate FG-labeled neurons that are CGRP-negative. Numbers of FG-labeled,
CGRP-ir neurons decrease in control and ESWT groups. The scale bar is 100 mm.expression in the DRG2 corresponds to robust hyperalgesia
in the OA knee model11. A CGRP antagonist reduces the re-
sponse of hyperexcitable spinal neurons to both innocuous
andnoxiouspressure applied to the inﬂamed joint12. After sci-
atic nerve sectioning in the rat, CGRP-ir in DRG neurons was
decreased13, and the rats demonstrated analgesia to heat
stimuli. Furthermore, there was a signiﬁcant decrease in the
number of CGRP-ir DRG neurons in rofecoxib-treated rats,
which was also correlated with behavioral data where hyper-
sensitivity was signiﬁcantly reduced4. We previously re-
ported that application of shock waves to normal rat skin
reduced the number of CGRP-ir sensory nerve ﬁbers9 in
the foot pad with the reduction of CGRP expression in DRG
neurons14. However, one of the limitations of those studies
was that the shock waves were applied under normal condi-
tions. Whether the same mechanism would operate under
pathological conditions is unknown.Behavioral examination also revealed the effectiveness
of ESWT. Walking duration was extended during a 14-day
period after ESWT. This result is consistent with reinnerva-
tion of free nerve endings 2 weeks after ESWT9. A limitation
of this study is that changes in the number of CGRP-ir DRG
neurons were not examined over time. The number of
CGRP-ir DRG neurons may increase again by day 21, as
found for nerve ﬁbers in rat skin9. Another limitation of this
study is that we did not examine the anatomical joint out-
come after ESWT. Further study is necessary to clarify
the long-term anatomical outcome.
Although there are many reports regarding the use of
ESWT to treat orthopedic disorders5,6, there were none
speciﬁcally for knee OA. Since ESWT does not cause dam-
age to the joint cartilage of growing rabbits15, side effects
are anticipated to be rare. Therefore, the use of ESWT is
recommended for knee OA prior to surgical treatment.
1096 N. Ochiai et al.: ESWT improves motor dysfunction and pain originating from knee OA in ratsThe current ﬁnding of reduced CGRP expression in DRG
neurons provides, at least in part, possible explanation for
pain relief following ESWT in knee OA, with a concomitant
improvement in walking ability lasting for 2 weeks. There-
fore, these data show that ESWT may be a useful treatment
for knee OA.
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